> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Glaucoma polygenic risk score finds tenfold open-angle glaucoma odds in the top decile
- URL: https://www.coios.me/glaucoma-polygenic-risk-score-finds-tenfold-open-angle/
- Published: 2026-11-15T11:39:33.000Z
- Updated: 2026-11-15T12:24:33.000Z
- Description: A multitrait glaucoma polygenic risk score gave tenfold odds in its top decile and predicted earlier diagnosis and glaucoma operations.
- Author: Daniel Ryan
- Tags: Data, models and systems, What linked data reveals, Australia, United States, United Kingdom, #peer-reviewed, #refines, #item, #source-2026-11, #score-65

Researchers built a polygenic risk score for open-angle glaucoma using genome-wide association data from more than 6 million people. The score combined related traits, including intraocular pressure, optic disc parameters and ocular hypertension. Top-decile odds ratios versus the rest were 10.04 in Australian, 9.09 in US and 4.91 in UK Biobank Europeans. The highest decile developed glaucoma about 25 years earlier than the lowest, with about 100-fold odds (odds ratio 96.83). Performance was weaker in other ancestries. Top-decile odds ratios were 4.01 in South Asian, 3.39 in East Asian and 2.26 to 3.81 in African ancestry.

*Why it is interesting: About half of open-angle glaucoma cases are undiagnosed, despite effective treatments. The score links inherited variation to age at diagnosis and glaucoma operations, but performs less well outside European ancestry.*

Source

[Ophthalmology, 12 November 2026](https://doi.org/10.1016/j.ophtha.2026.10.013?ref=coios.me)

Paper

Step change in glaucoma polygenic risk score performance enables clinical utility

Authors

MacGregor S, Ni G, Seviiri M, Kolovos A, Le NQ, Hassall MM et al.

DOI

10.1016/j.ophtha.2026.10.013

Type

Peer-reviewed article

Design

Multi-ancestry genetic association and risk-prediction study; GWAS data from >6 million individuals, validated in Australian, US and UK Biobank cohorts

Verdict

Refines prior evidence

Driver

[What linked data reveals](https://www.coios.me/d-linked-data/)

Abstract — the authors' own words, CC BY

Purpose

Open-angle glaucoma (OAG) is the leading cause of irreversible blindness and is highly heritable. Despite effective treatments, approximately 50% of cases remain undiagnosed. We aimed to develop and validate a clinically applicable, genetics-based risk prediction tool for OAG across diverse ancestries. Design

Genetic association study and risk prediction analysis. Participants

More than 6 million individuals contributing genome-wide association study data from multiple ancestry groups. Methods

We constructed a comprehensive polygenic risk score (PRS) for OAG using a multitrait modeling framework that integrated glaucoma-related traits, including intraocular pressure, optic disc parameters, and ocular hypertension. PRS performance was evaluated for OAG risk across major ancestry groups and assessed for associations with age at diagnosis, treatment escalation, surgical outcomes, and familial risk. Main outcome measures

Odds ratios (ORs) for OAG by PRS percentile, age at disease onset, absolute risk estimates, treatment escalation, glaucoma surgery, and OAG risk in first-degree relatives. Results

In Australian individuals of European ancestry, those in the top 10% of the PRS distribution had a 10-fold increased risk of OAG compared with the remainder (OR 10.04, 95% CI 7.43-13.59), substantially outperforming our previously published PRS (OR 4.2). Similar performance was observed in U.S. European ancestry data (OR 9.09, 95% CI 5.09-16.26). In UK Biobank Europeans the OR for the top 10% versus the remainder was 4.91 (95% CI 4.25-5.69). Although performance was attenuated in other ancestry groups (OR top 10% vs. remainder: 4.01 in South Asian, 3.39 in East Asian, and ranging from 2.26 to 3.81 in African ancestry populations depending on cohort), high PRS percentiles corresponded to elevated absolute risk across all groups. On average, individuals in the highest-risk decile developed glaucoma approximately 25 years earlier than those in the lowest decile and had ∼100-fold (OR 96.83, 95% CI 52.61-178.21) higher risk. The PRS also predicted treatment escalation in early disease, prevalent and incident glaucoma surgery, and OAG risk among first-degree relatives. Conclusions

This enhanced PRS, available for clinical use through an accredited genotyping workflow, enables effective risk stratification for OAG across diverse ancestries, facilitating earlier identification and treatment of high-risk individuals while supporting resource rationalisation for those at low risk. Performance is strongest in European ancestry populations, and further work is needed to improve equity of performance across ancestries.